These findings come in agreement with a previous study by Du et al. [8] which was carried on 380 diabetic patients, and they concluded that the baseline ApoB/ApoA-1 was typically superior to other lipid and lipoprotein parameters in predicting high GS (scores ≥ 47) in diabetic patients with newly diagnosed CAD. This evidence concerns the gene APOB and coronary artery disorder.